, the study or prostate cancer. Equol was tested in rats performed at Colorado State University, Brigham Young University and Cincinnati Children ‘s and appears in the April issue of Biology of Reproduction.
Directly binding and inactivating DHT without influencing testosterone gives equol the ability to reduce many of the harmful effects of androgens without the beneficial ones, said Robert J. To senior study author and professor in the Department of Biomedical Sciences Colorado State College of Veterinary Medicine. Setchell novelty of equol is that it both inhibits androgen hormone and influences estrogen hormone action, adds Edwin Lephart, Professor of Physiology and Developmental Biology and Director of the the Neuroscience Center at Brigham Young University. We have no other molecule that has to know these important biochemical properties. . Continue reading